Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innov. LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.025p +0.92% 2.75p 401,002 08:07:42
Bid Price Offer Price High Price Low Price Open Price
2.70p 2.80p 2.75p 2.725p 2.725p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 8.75 0.54 0.10 27.5 21.5

Surgical Innovations (SUN) Latest News

More Surgical Innovations News
Surgical Innovations Takeover Rumours

Surgical Innovations (SUN) Share Charts

1 Year Surgical Innovations Chart

1 Year Surgical Innovations Chart

1 Month Surgical Innovations Chart

1 Month Surgical Innovations Chart

Intraday Surgical Innovations Chart

Intraday Surgical Innovations Chart

Surgical Innovations (SUN) Discussions and Chat

Surgical Innovations Forums and Chat

Date Time Title Posts
12/12/201816:08(Surging) Surgical Innovations4,679
25/3/201622:13Surgical Innovations : A New BOD & A New Future6
14/2/201221:44Where's the thread gone?1
04/10/201108:25Surgical Innovation...cutting edge technology5,573

Add a New Thread

Surgical Innovations (SUN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Surgical Innovations trades in real-time

Surgical Innovations (SUN) Top Chat Posts

Surgical Innovations Daily Update: Surgical Innov. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 2.73p.
Surgical Innov. has a 4 week average price of 2.60p and a 12 week average price of 2.60p.
The 1 year high share price is 4.08p while the 1 year low share price is currently 1.75p.
There are currently 782,566,177 shares in issue and the average daily traded volume is 464,912 shares. The market capitalisation of Surgical Innov. is £21,520,569.87.
bashor: What is it going to take to get this share price back to the 4-4.5p Range? good solid growth this year and a positive outlook for 2019, with free cash flow to backup a share buyback, that’s my wish list for Xmas, am I been too reserved with the 4-4.5p target
bashor: Predictions for the closing share price Tuesday
xylemflow: New to this thread but have a small shareholding. I don't understand the comment from Van Zandt. Sour grapes or naivety? None of the companies that i invest in offer much detail at all in an update. Surely as a shareholder you'd be pleased to hear that the company is doing quite well and the share price has gone up by 10%?
bashor: The single word within the outlook that caused the pullback was "satisfactory" the share price was heady and needed much better than satisfactory to be sustainable IMO
buywell3: Correct IF I am right the future for SUN looks golden 4.65p now the BID Not that I am selling any ... I have not sold a single SUN share since I acquired my maiden tranche kindly donated by gbh2
van zandt: Hello again, Things are moving; I was away for a few days as has been reported I did not have a clue. Things are improving now and with the Sun share price and I was able to see my registrar in fact she is a Senior Registrar. She advised me not to worry about my dreams of 8 in fact she was very reassuring and told me it is very common when you have 8 in a dream it is because one has unknowingly come into contact with secret dork and that the dork has been sniffing the 8 ball. I think I understand. As ever regards VZ
buywell3: The mesh market is set to grow will post on that tomorrow Re microline below ......see this hTTp:// Check it out and think Surgical to buy NHS supplier in "natural next step" Published: 16:55 Thursday 27 July 2017 ​K​eyhole surgery instrument​s​ maker Surgical Innovations ​​is to buy ​​Elemental Healthcare​, ​​a̴3;n NHS medical products ​supplier,R03; ​for £9.4m​.​ ​Leeds-based Surgical​̴3; ​said Elemental is already well known to​ the firm as ​the exclusive distributor of SI branded products in the UK​. It said that​ the acquisition of a profitable and cash generative distributor is expected to have an immediate positive impact on Surgical’s ​margins and profitability. ​​Nigel Rogers, ​e​xecutive ​c​hairman of Surgical​, said: “Coming together was the natural next step for two businesses that have had such a long-standing and​ ​fruitful partnership​. ​​“Adam and David, the​ ​principals at Elemental, have a great pedigree in the medical device section and ​we ​look forward to benefiting​ ​from their insights into our new product initiatives and business development here and abroad.” Elemental is owned by co-founders Adam Power and David Marsh, who will both join the Board of Surgical​ ​Innovations ​​as ​g​roup ​d​evelopment ​d​irector and ​g​roup ​c​ommercial ​director, respectively. The business​ ​employs 19 staff ​in Berkshire, including a sales team of 12. Surgical announced a ​p​lacing and ​s​ubscription to raise £5.5m at a placing price of 3p​ ​through stockbroker WH Ireland​ to help fund the deal. The proceeds will be used to fund the acquisition, alongside existin​g ​cash resources and a new £2.5m debt facility with Yorkshire Bank. Surgical will pay a total of​ ​£7.5m in cash to ​Mr ​Power and ​Mr ​Marsh, as well ​as ​issuing them shares worth £1.875m, approximately 8​ per cent​ of the​ ​enlarged company. The Surgical ​b​oard ha​s​ also invested in the fundrais​ing​, to the tune of £82,500 between​ ​them. ​ Mr Rogers said: “There are clear and obvious benefits to margins and​ ​earnings as we add a highly profitable and cash generative business to the group, but this also provides us with access to an experienced direct sales force and the new products distributed by Elemental will widen​ ​the range of products on offer to surgeons in the NHS and UK private hospitals. “All acquisitions have some integration risks attached to them, but having worked with the Elemental team​ ​and having such a high level of inter-dependency we expect this will ease the integration process.” Elemental has been ​the ​distributor for SI branded products since its inception in 2007​. It also handles UK​ ​distribution of Microline Surgical​'s complementary range of laparoscopic instruments, bariatric products on​ ​behalf of GI Dynamics, hernia repair products for Cousin Biotech and P​e​ters Surgical, and breast​ ​reconstruction products for Meccellis Biotech. Over the last year the combined businesses would have produced annual sales of around £12m and a pre-tax profit of around £1.4m. Eric Burns, ​d​irector of ​r​esearch at WH Ireland, said: “We have argued for some​ ​time that Surgical Innovations offers investors a platform for building a much larger healthcare business on​ ​AIM and the Elemental deal is a major first step in this direction. With the substantial resources of a PLC​ ​owner behind it we think there’s good scope for Elemental to significantly increase its product portfolio as​ ​well as bringing a direct sales force to Surgical from day one.” In March, Surgical announced a​n 11 per cent increase in annual sales to £6.1m​,​ mainly driven by favourable export​ ​conditions in what the group described at the time as a breakout year. Results for 2016 marked a return to ​the ​black with a £280,000 profit compared ​with​ a pre-tax loss of £2.1m in​ ​2015. The share price fell initially in reaction to the discounted placing to 3.25p before recovering later in the day​ ​to finish ​at 3.5​8p. hTTp:// clues Microline Surgical 50 Dunham Road, Suite 1500 Beverly, MA 01915 USA hTTp:// hTTp://
meijiman: Assume interims will be end August. Have to think that the statement will be positive-therefore buy the shares ahead? Or is there a flaw in my reasoning! Great posts buywell as before -almost re-energised myself to do more research here. The SUN share price should be capable of once again getting back into double figures if things go to plan.
meijiman: Well where we are now is alot better place than under the previous management. The finance sections in the RNS seem solid enough. Cash generation has allowed one acquisition plus the early paydown of some debt.Think the issue for most is that they bought into a long term growth story. Don't think many bought SUN as a trading stock. The time to sell was to follow the previous ceo who piled out big time somewhere north of 10p. I'm now of the view that a double figures share price will once again be achievable for those with a modicum of patience.
gnnmartin: I guess some people were hoping for slightly more from the January update. The share price has come back a bit but still anticipates quite a lot of further improvement at the company. I think the share price is reasonable and I'll continue to hold. At my age I'm tending to cash in rather than invest more.
Surgical Innovations share price data is direct from the London Stock Exchange
Your Recent History
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181213 19:05:32